Results 141 to 150 of about 1,725 (152)

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

New England Journal of Medicine, 2014
Loïc Guillevin, Christian Pagnoux, Alexandre Karras   +2 more
exaly  

Genetically Distinct Subsets within ANCA-Associated Vasculitis

New England Journal of Medicine, 2012
Paul A Lyons, Timothy F Rayner, Richard A Watts   +2 more
exaly  

Long-term patient survival in ANCA-associated vasculitis

Annals of the Rheumatic Diseases, 2011
Lorraine Harper, Peter Höglund, David Jayne   +2 more
exaly  

Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis

New England Journal of Medicine, 2013
Ulrich Specks, Peter A Merkel, Philip Seo   +2 more
exaly  

Current and emerging techniques for ANCA detection in vasculitis

Nature Reviews Rheumatology, 2014
Frank Moosig
exaly  

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Annals of the Rheumatic Diseases, 2018
Pierre Charles, Benjamin Terrier
exaly  

CRULIC – WEG INS JENSEITS (Crulic – Drumul spre dincolo, 2011), R: Anca Damian

openaire   +1 more source

B cell therapy in ANCA-associated vasculitis: current and emerging treatment options

Nature Reviews Rheumatology, 2018
Seerapani Gopaluni Mbbs, Mrcp, David Jayne, Rachel B Jones   +2 more
exaly  

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

Nature Communications, 2019
Paul A Lyons, James E Peters, Federico Alberici   +2 more
exaly  

Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis

New England Journal of Medicine, 2008
Christian Pagnoux, Alfred D Mahr, Marc Lambert   +2 more
exaly